CN Stock MarketDetailed Quotes

603233 DaShenLin Pharmaceutical Group

Watchlist
  • 12.97
  • -0.28-2.11%
Market Closed Sep 10 15:00 CST
14.77BMarket Cap16.29P/E (TTM)

DaShenLin Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

DaShenLin Pharmaceutical Group Q2 2024 Earnings Date

Currency：CNYAug 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
7.26B
6.59B
-665.45M
Miss Est.
+20.08%
+9.07%
-9.17%
Net Income
--
247.41M
--
-42.42%
Analyst Rating
Strong Buy

Sep 10, 2024

DaShenLin Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 7.737B--
--2024/Q3-- / 6.331B--
Aug 31, 20242024/Q26.593B / 7.259B--
--2024/Q16.752B / 6.842B--
--2023/Q46.808B / 6.760B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 7.737B--
--2024/Q3-- / 6.331B--
Aug 31, 20242024/Q26.593B / 7.259B--
--2024/Q16.752B / 6.842B--
--2023/Q46.808B / 6.760B--

Unlock Free Earnings Estimates

DaShenLin Pharmaceutical Group Earnings Reports

  • Dashenlin Pharmaceutical Group Co., Ltd. 2024 Semi-Annual Report

    Aug 30 12:00 ET

  • Summary of the 2024 semi-annual report of Dashenlin Pharmaceutical Group Co., Ltd.

    Aug 30 12:00 ET

  • Summary of the 2023 Annual Report of Dashenlin Pharmaceutical Group Co., Ltd.

    Apr 28 12:00 ET

  • Dashenlin Pharmaceutical Group Co., Ltd. 2023 Annual Report

    Apr 28 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 10, 2024

    Strong Buy

    • Strong Buy

      82.35%

    • Buy

      17.65%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg